Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy
暂无分享,去创建一个
H. Hoogsteden | J. Aerts | R. Hendriks | J. Hegmans | H. Vroman | K. Bezemer | R. Cornelissen | Lisanne Noordam | Margaretha E.H. Kaijen | L. Maat